Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSection Navigation
Section Navigation
- Module 6 Overview
Treatment of Key Populations and Unique Situations - 0%Lesson 1
Treatment of HCV in Persons with HIV CoinfectionActivities- 0%Lesson 2
Treatment of HCV in Persons with Renal ImpairmentActivities- 0%Lesson 3
Treatment of HCV in Persons with Substance UseActivities- 0%Lesson 4
Treatment of HCV in a Correctional SettingActivities- 0%Lesson 5
Management of Health Care Personnel Exposed to HCVActivities- 0%Lesson 6
Perinatal HCV TransmissionActivitiesActivity 1B. DHHS Guidelines for HCV-HIV Coinfection
Learning Objective Performance Indicators
- Explain the impact of HIV on the progression of liver fibrosis in persons with untreated chronic HCV
- Describe current HCV treatment approaches in persons with HIV coinfection
- Discuss HCV treatment responses in persons with HIV and HCV coinfection compared with responses in persons with HCV monoinfection
- Summarize recommendations for treating HIV in persons with HCV and HIV coinfection
- List key drug interactions between HCV direct-acting antivirals and HIV antiretroviral medications
Instructions
The Department of Health and Human Resources HIV Antiretroviral Therapy Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV has a section devoted to Hepatitis C Virus-HIV coinfection. This section provides an excellent succinct overview of this topic.1. Click on the link and review the Panel's Recommendations regarding Hepatitis C Virus-HIV coinfection.
2. Scroll down and see Table 15—Concomitant Use of Selected Antiretroviral Drugs and Hepatitis C Virus Direct-Acting Antiviral Drugs for Treatment of Hepatitis C Virus in Adults with HIV.
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-c8843673-2024-11-13-205624